Henry L. Nordhoff
Henry L. Nordhoff has been one of our directors since March 2005. He has served
as a director of BioTime, Inc. since June 2013 and as a director of Asterias
Biotherapeutics, Inc. since October 2013. Mr. Nordhoff retired as Chairman of
the Board of Gen-Probe Incorporated, a clinical diagnostic and blood screening
company, at the end of 2011, after serving as its Chairman since September 2002.
He also served as Chief Executive Officer and President of Gen-Probe from July
1994 until May 2009. Prior to joining Gen-Probe, he was President and Chief
Executive Officer of TargeTech, Inc., a gene therapy company that was merged
into Immune Response Corporation. Prior to that, Mr. Nordhoff was at Pfizer,
Inc. in senior positions in Brussels, Seoul, Tokyo and New York. He received a
B.A. in international relations and political economy from Johns Hopkins
University and an M.B.A. from Columbia University.